-
1
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
2
-
-
0026440636
-
Drug therapy: Chemotherapy of lung cancer
-
Ihde DC: Drug therapy: Chemotherapy of lung cancer. N Engl J Med 327:1434-1441, 1992
-
(1992)
N Engl J Med
, vol.327
, pp. 1434-1441
-
-
Ihde, D.C.1
-
3
-
-
84994521433
-
Drug therapy: Paclitaxel (Taxol)
-
Rowinsky EK, Donehower RC: Drug therapy: Paclitaxel (Taxol). N Engl J Med 332:1004-1014, 1995
-
(1995)
N Engl J Med
, vol.332
, pp. 1004-1014
-
-
Rowinsky, E.K.1
Donehower, R.C.2
-
4
-
-
0027412646
-
Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer
-
Murphy WK, Fossella FV, Winn RJ, et al.: Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384-388, 1993
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 384-388
-
-
Murphy, W.K.1
Fossella, F.V.2
Winn, R.J.3
-
5
-
-
0027537911
-
Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results
-
Chang AY, Kim K, Glick J, et al.: Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388-394, 1993
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 388-394
-
-
Chang, A.Y.1
Kim, K.2
Glick, J.3
-
6
-
-
0029003733
-
Paclitaxel by 1-hour infusion: An active drug in metastatic non-small-cell lung cancer
-
Hainsworth JD, Thompson DS, Greco FA: Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer. J Clin Oncol 13:1609-1614, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1609-1614
-
-
Hainsworth, J.D.1
Thompson, D.S.2
Greco, F.A.3
-
7
-
-
9044222488
-
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer
-
Millward MJ, Bishop JF, Friedlander M, et al.: Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol 14:142-148, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 142-148
-
-
Millward, M.J.1
Bishop, J.F.2
Friedlander, M.3
-
8
-
-
0029071979
-
Phase II study of paclitaxel in patients with extensive-stage small cell lung cancer: An Eastern Cooperative Oncology Group study
-
Ettinger DS, Finkelstein DM, Sarma RP, et al.: Phase II study of paclitaxel in patients with extensive-stage small cell lung cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 13:1430-1435, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1430-1435
-
-
Ettinger, D.S.1
Finkelstein, D.M.2
Sarma, R.P.3
-
9
-
-
0028175116
-
The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines
-
Liebmann J, Cook JA, Lipschultz C, et al.: The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines. Cancer Chemother Pharmacol 33:331-339, 1994
-
(1994)
Cancer Chemother Pharmacol
, vol.33
, pp. 331-339
-
-
Liebmann, J.1
Cook, J.A.2
Lipschultz, C.3
-
10
-
-
0029050938
-
Four-day paclitaxel infusion with cisplatin for patients with lung cancer
-
Georgiadis MS, Schuler B, Johnson BE: Four-day paclitaxel infusion with cisplatin for patients with lung cancer. Semin Oncol 22:67-69, 1995
-
(1995)
Semin Oncol
, vol.22
, pp. 67-69
-
-
Georgiadis, M.S.1
Schuler, B.2
Johnson, B.E.3
-
11
-
-
0028110931
-
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/ II trial of 96-hour infusion
-
Wilson WH, Berg SL, Bryant G, et al.: Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/ II trial of 96-hour infusion. J Clin Oncol 12:1621-1629, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 1621-1629
-
-
Wilson, W.H.1
Berg, S.L.2
Bryant, G.3
-
12
-
-
0028817461
-
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphoma
-
Wilson WH, Chabner BA, Bryant G, et al.: Phase II study of paclitaxel in relapsed non-Hodgkin's lymphoma. J Clin Oncol 13:381-386, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 381-386
-
-
Wilson, W.H.1
Chabner, B.A.2
Bryant, G.3
-
13
-
-
0025850566
-
Sequences of Taxol and cisplatin: A phase I and pharmacologic study
-
Rowinsky EK, Gilbert MR, McGuire WP, et al.: Sequences of Taxol and cisplatin: A phase I and pharmacologic study. J Clin Oncol 9:1692-1703, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 1692-1703
-
-
Rowinsky, E.K.1
Gilbert, M.R.2
McGuire, W.P.3
-
14
-
-
0001770154
-
Appendix A: Grading of Toxicity
-
Philadelphia, PA, Lippincott
-
Wittes RE: Appendix A: Grading of Toxicity, in Manual of Oncologic Therapeutics 1989/1990. Philadelphia, PA, Lippincott, 1989, pp 445-448
-
(1989)
Manual of Oncologic Therapeutics 1989/1990
, pp. 445-448
-
-
Wittes, R.E.1
-
15
-
-
12044258548
-
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing
-
Shaw GL, Gazdar AF, Phelps R, et al.: Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 5181-5187
-
-
Shaw, G.L.1
Gazdar, A.F.2
Phelps, R.3
-
16
-
-
0028149937
-
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
-
Ihde DC, Mulshine JL, Kramer BS, et al.: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 2022-2034
-
-
Ihde, D.C.1
Mulshine, J.L.2
Kramer, B.S.3
-
17
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.1
Meier, P.2
-
18
-
-
0027504607
-
2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer
-
2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer. Cancer Chemother Pharmacol 33:48-52, 1993
-
(1993)
Cancer Chemother Pharmacol
, vol.33
, pp. 48-52
-
-
Jamis-Dow, C.A.1
Klecker, R.W.2
Saosy, G.3
-
19
-
-
0028154069
-
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
-
Le Chevalier T, Brisgand D, Douillard JY, et al.: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 360-367
-
-
Le Chevalier, T.1
Brisgand, D.2
Douillard, J.Y.3
-
20
-
-
0029098178
-
Paclitaxel and carboplatin in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis
-
Langer CJ, Leighton JC, Comis RL, et al.: Paclitaxel and carboplatin in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1860-1870
-
-
Langer, C.J.1
Leighton, J.C.2
Comis, R.L.3
-
21
-
-
0000719909
-
Phase III trial comparing etoposide-cisplatin versus Taxol with cisplatin-G-CSF versus Taxol-cisplatin in advanced non-small cell lung cancer
-
An Eastern Cooperative Oncology Group trial. abstr 1145
-
Bonomi P, Kim K, Chang A, et al.: Phase III trial comparing etoposide-cisplatin versus Taxol with cisplatin-G-CSF versus Taxol-cisplatin in advanced non-small cell lung cancer. An Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 15:382, 1996 (abstr 1145)
-
(1996)
Proc Am Soc Clin Oncol
, vol.15
, pp. 382
-
-
Bonomi, P.1
Kim, K.2
Chang, A.3
-
22
-
-
0029148461
-
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage therapy for metastatic breast cancer
-
Seidman AD, Tiersten A, Hudis C, et al.: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage therapy for metastatic breast cancer. J Clin Oncol 13:2575-2581, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2575-2581
-
-
Seidman, A.D.1
Tiersten, A.2
Hudis, C.3
-
23
-
-
0029946928
-
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
-
Seidman AD, Hochhauser D, Gollub M, et al.: Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. J Clin Oncol 14:1877-1884, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 1877-1884
-
-
Seidman, A.D.1
Hochhauser, D.2
Gollub, M.3
-
24
-
-
0023254952
-
In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy
-
Wolff SN, Grosh WW, Prater K, et al.: In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy. Cancer Chemother Pharmacol 19:246-249, 1987
-
(1987)
Cancer Chemother Pharmacol
, vol.19
, pp. 246-249
-
-
Wolff, S.N.1
Grosh, W.W.2
Prater, K.3
-
25
-
-
0024417601
-
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
-
Slevin ML, Clark PI, Joel SP, et al.: A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol 7:1333-1340, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 1333-1340
-
-
Slevin, M.L.1
Clark, P.I.2
Joel, S.P.3
-
26
-
-
0027360291
-
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting
-
Rowinsky EK, Chaudhry V, Forastiere AA, et al.: Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting. J Clin Oncol 11:2010-2020, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 2010-2020
-
-
Rowinsky, E.K.1
Chaudhry, V.2
Forastiere, A.A.3
-
27
-
-
0027999966
-
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
-
Eisenhauer EA, Huinink WW, Swenerton KD, et al.: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion. J Clin Oncol 12:2654-2666, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 2654-2666
-
-
Eisenhauer, E.A.1
Huinink, W.W.2
Swenerton, K.D.3
-
28
-
-
0027093094
-
Taxol administered as a 120 hour infusion
-
Spriggs DR, Tondini C: Taxol administered as a 120 hour infusion. Invest New Drugs 10:275-278, 1992
-
(1992)
Invest New Drugs
, vol.10
, pp. 275-278
-
-
Spriggs, D.R.1
Tondini, C.2
-
29
-
-
0018591945
-
Toxic effects of cis-dichlorodiammineplatinum(II) in man
-
Von Hoff DD, Schilsky R, Reichert CM, et al.: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63:1527-1531, 1979
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 1527-1531
-
-
Von Hoff, D.D.1
Schilsky, R.2
Reichert, C.M.3
-
30
-
-
0022461326
-
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer
-
Kris MG, Gralla RJ, Wertheim MS, et al.: Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep 70:1091-1096, 1986
-
(1986)
Cancer Treat Rep
, vol.70
, pp. 1091-1096
-
-
Kris, M.G.1
Gralla, R.J.2
Wertheim, M.S.3
-
31
-
-
0021850136
-
Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide
-
Scagliotti GV, Lodico D, Gozzelino F, et al.: Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide. Oncology 42:224-228, 1985
-
(1985)
Oncology
, vol.42
, pp. 224-228
-
-
Scagliotti, G.V.1
Lodico, D.2
Gozzelino, F.3
-
32
-
-
0019492001
-
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
-
Gralla RJ, Casper ES, Kelson DP, et al.: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med 95:414-420, 1981
-
(1981)
Ann Intern Med
, vol.95
, pp. 414-420
-
-
Gralla, R.J.1
Casper, E.S.2
Kelson, D.P.3
|